Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. [electronic resource]
Producer: 20060612Description: 753-9 p. digitalISSN:- 0003-4967
- Adalimumab
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Male
- Methotrexate -- adverse effects
- Middle Aged
- Prospective Studies
- Remission Induction
- Time Factors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.